SECTION 13. Cervical screening for women exposed to diethylstilbestrol Name Organisation Feedback Aroha Morgan, Maori Health, Lakes Non applicable from a non-clinical perspective. Phyllis Tangitu and District Health Board Trish Solomon Dr Vicki Robertson West Coast DHB No additional comments. We support these recommendations. Beth Henderson WWFT This means we will have to ask every women born from 1940 to 1980 if their mother took DES. I am sure most women would have no idea what then? Should we be co-testing all women born in those years? – Respondent’s Waikato DHB Good practical advice. name redacted at request. Pip Egerton Tuatapere and Was NOT of this group no knowledge that this group of women have an increased risk of clear cell –had Otautau Medical carcinoma of the vagina and cervix. Would be interested to know how many other smear takers are aware. Centres Other evidence/info to consider: How best to identify these women in our practice??? Especially considering they should be offered annual testing Fiona Moscrop Compass Health Acceptable. CWH & CHL - Collaborative Support recommendations. This is a minority group. Refer Section 1 feedback CWH and CHL Drs Jay Sirisena, Northland Should the smear be from cervix only or should the vagina also be smeared? Anand Gangi, Colposcopy Jenny Blasingame, Services Kristy Wolff, Donna Hardie Dr Gillian Gibson RANZCOG 13.01 colposcopic examination of both the cervix and vagina indefinitely” is this annual colposcopy as “and well or just if an abnormal HPV test or co-test? Annette Davis Hawkes Bay DHB Agree. Howard Clentworth CCDHB The last time Diethylstilboestrol was used in pregnant worldwide was 1971 and in New Zealand in 1968. Gynaecology Dept. All of those women have been screened multiple times they are now 50. The section is simply redundant.
SECTION 13. Cervical screening for women exposed to diethylstilbestrol Name Organisation Feedback Aroha Morgan, Phyllis Tangitu and Trish Solomon Maori Health, Lakes District Health Board Non applicable from a non-clinical perspective. Dr Vicki Robertson West Coast DHB No additional comments. We support these recommendations. Beth Henderson WWFT This means we will have to ask every women born from 1940 to 1980 if their mother took DES. I am sure most women would have no idea – what then? Should we be co-testing all women born in those years? Respondent’s name redacted at request. Waikato DHB Good practical advice. Pip Egerton Tuatapere and Otautau Medical Centres Was NOT of this group –had no knowledge that this group of women have an increased risk of clear cell carcinoma of the vagina and cervix. Would be interested to know how many other smear takers are aware. Other evidence/info to consider: How best to identify these women in our practice??? Especially considering they should be offered annual testing Fiona Moscrop Compass Health Acceptable. CWH & CHL - Refer Section 1 Collaborative feedback CWH and CHL Support recommendations. This is a minority group. Drs Jay Sirisena, Anand Gangi, Jenny Blasingame, Kristy Wolff, Donna Hardie Northland Colposcopy Services Should the smear be from cervix only or should the vagina also be smeared? Dr Gillian Gibson RANZCOG 13.01 “and colposcopic examination of both the cervix and vagina indefinitely” is this annual colposcopy as well or just if an abnormal HPV test or co-test? Annette Davis Hawkes Bay DHB Agree. Howard Clentworth CCDHB Gynaecology Dept. The last time Diethylstilboestrol was used in pregnant worldwide was 1971 and in New Zealand in 1968. All of those women have been screened multiple times they are now 50. The section is simply redundant.
consultation-feedback-uupdated-clinical-practice-guidelines-cervical-screening-nz-aug17.docx